期刊文献+

宫颈癌宫体浸润诊断及治疗策略:附27例报告 被引量:2

Clinical diagnosis and treatment strategy in cervical cancer with invasion of uterine body:analysis of 27 cases
下载PDF
导出
摘要 目的:通过分析宫颈癌宫体浸润的病例资料,为临床诊治提供依据。方法:回顾性分析本院2009-05~2015-12收治的27例宫颈癌宫体浸润患者的临床表现、诊断方法、手术方式及病理结果。结果:27例患者中40.7%表现为阴道不规则流血,37.0%表现为阴道排液,22.2%无明显症状,仅为体检发现。HPV感染分型16型及18型占96.3%,9例患者术前MRI结果示:子宫内膜癌,病检结果示:8例为宫颈癌,1例子宫内膜鳞癌;18例MRI结果示:宫颈癌。术后随诊,平均生存时间16个月,平均生存率22.2%。结论:宫颈癌宫体浸润的诊断及治疗需结合病史、HPV及TCT筛查结果、阴道镜术前以及术后病理活检结果综合评估。 Objective:To investigate the clinical diagnosis and treatment stategy of uterine body of cervical cancer.Methods:The clinical manifestations,diagnostic methods,surgical methods,surgical methods and pathological findings of 27 cases of uterine body of cervical cancer who treated in our hospital from May 2009 to December 2015.Results:The 40.7% of patients showed irregular vaginal bleeding,37.0% showed irregular vaginal fluiding,22.2%was physical findings.Mostly patients were HPV16,18,Ratio was 96.3%.The preoperative MRI results in 9patients were showen:endometrial cancers,the postoperative pathologicexamination results showed that 8cases of cervical cancer.1cases of endometrial squamous cell carcinoma.The preoperative MRI results in 18 patients were showen:cervical cancer.The postoperative follow-up results showed that the average survival time was 16 months,and the average survival rate was 22.2%.Conclusion:Diagnosis of uterine body of cervical cancer should be combined with history,screening result,colposcopy diagnosis and the pathological result of biopsy.
出处 《西北国防医学杂志》 CAS 2017年第5期301-303,共3页 Medical Journal of National Defending Forces in Northwest China
基金 国家自然科学基金资助项目(81260387) 甘肃省自然科学基金资助项目(1208RJZ109)
关键词 宫颈癌 宫体浸润 子宫内膜鳞癌 DA Vinci机器人 cervical cancer invasion of uterine body endometrial squamous cell carcinoma Da Vinci Robot
  • 相关文献

参考文献5

二级参考文献53

  • 1Feday J,Shin H, Bray F,et al. GLOBOCAN 2008,cancer incidence and mortality worldwide: IARC CancerBase No.10[EB/OL]. Lyon:International Agency for Research on Cancer, 2010.
  • 2de Villiers EM, Fauquet C, Broker TR,et al. Classification of papillomavimses[J]. Virology, 2004,324(1): 17-27.
  • 3IARC monographs on the evaluation of carcinogenic risks to humans. Human Papillomavirus[M]. Volmne 64.1995.64.
  • 4Ahekruse SF,Lacey JJ,Brinton LA,et al. Comparison of human papillomavirus genotypes,sexual,and reproductive risk factors of celvical adenocarcinoma and squamous cell careinoma: Northeastern United States [J]. Am J Obstet Gynecol, 2003,188(3):657-663.
  • 5Pirog EC,Kleter B,Olgac S,et al. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma [J]. Am J Pathol,2000,157 (4): 1055-1062.
  • 6Altekmse SF,Lacey JJ,Brinton LA,et al. Comparison of human papillomavirus genotypes,sexual,and reproductiverisk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States [J]. Am J Obstet Gynecol, 2003,188(3):657-663.
  • 7de Cremoux P,de la Rochefordiere A,Savignoni A,et al. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype [J]. Int J Cancer,2009,124(4):778-782.
  • 8Alemany L,Perez C,Tous S,et al. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention [J]. Gynecol 0ncol,2012,124 (3):512-517.
  • 9de Sanjose S,Quint WG,Alemany L,et al. Human papil- lomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study [J]. Lancet Oncol,2010, 11(11):1048-1056.
  • 10Wheeler CM,Hunt WC,Joste NE,et al. Human papillo- mavirus genotype distributions: implications for vaccina- tion and cancer screening in the United States [J]. J Natl Cancer Inst, 2009,101(7):475-487.

共引文献43

同被引文献20

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部